140 related articles for article (PubMed ID: 16648049)
1. Aplastic anaemia in patient with glioblastoma multiforme treated with temozolomide.
Villano JL; Collins CA; Manasanch EE; Ramaprasad C; van Besien K
Lancet Oncol; 2006 May; 7(5):436-8. PubMed ID: 16648049
[No Abstract] [Full Text] [Related]
2. A rare case of aplastic anemia caused by temozolomide.
George BJ; Eichinger JB; Richard TJ
South Med J; 2009 Sep; 102(9):974-6. PubMed ID: 19668033
[TBL] [Abstract][Full Text] [Related]
3. Unexpected case of aplastic anemia in a patient with glioblastoma multiforme treated with Temozolomide.
Jalali R; Singh P; Menon H; Gujral S
J Neurooncol; 2007 Oct; 85(1):105-7. PubMed ID: 17505778
[TBL] [Abstract][Full Text] [Related]
4. Aplastic anemia as a cause of death in a patient with glioblastoma multiforme treated with temozolomide.
Kopecký J; Priester P; Slovácek L; Petera J; Kopecký O; Macingova Z
Strahlenther Onkol; 2010 Aug; 186(8):452-7. PubMed ID: 20803286
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow transplantation for severe aplastic anemia secondary to temozolomide.
Morris EB; Kasow K; Reiss U; Ellison D; Broniscer A
J Neurooncol; 2009 Jan; 91(2):237-9. PubMed ID: 18818880
[TBL] [Abstract][Full Text] [Related]
6. An analysis of temozolomide-related adverse drug reactions reported to the medicines and healthcare products regulatory agency through the yellow card scheme aiming to characterise idiosyncratic profound bone marrow suppression tantamount to aplastic anaemia.
Dixit S; Hingorani M; Allgar V
Clin Oncol (R Coll Radiol); 2014 Feb; 26(2):120-1. PubMed ID: 24183933
[No Abstract] [Full Text] [Related]
7. Temozolomide-related acute lymphoblastic leukemia with translocation (4;11)(q21;q23) in a glioblastoma patient.
Chou KN; Lin YC; Liu MY; Chang PY
J Clin Neurosci; 2014 Apr; 21(4):701-4. PubMed ID: 24291476
[TBL] [Abstract][Full Text] [Related]
8. [Temozolomide, an oral chemotherapeutic agent with potential severe toxicity].
Soetekouw PM; Gijtenbeek JM; van der Maazen RW; Kappelle AC; van Herpen CM
Ned Tijdschr Geneeskd; 2007 Jan; 151(4):253-7. PubMed ID: 17323884
[TBL] [Abstract][Full Text] [Related]
9. Treatment-related Acute Myeloid Leukaemia After Temozolomide for Glioblastoma Multiforme.
Tan CW; See SJ; Tham CK; Ang AL
Ann Acad Med Singap; 2014 Jun; 43(6):334-7. PubMed ID: 25028145
[No Abstract] [Full Text] [Related]
10. Temozolomide induced bone marrow Suppression--A single institution outcome analysis and review of the literature.
Kourelis TV; Buckner JC; Gangat N; Patnaik MM
Am J Hematol; 2015 Sep; 90(9):E183-4. PubMed ID: 26010271
[No Abstract] [Full Text] [Related]
11. Drop metastases to the spinal cord from infratentorial glioblastoma multiforme in post-temozolomide era.
Pande SB; Pavithran K
J Cancer Res Ther; 2015; 11(4):1039. PubMed ID: 26881656
[TBL] [Abstract][Full Text] [Related]
12. Temozolomide-induced aplastic anaemia and incidental low-grade B-cell non-Hodgkin lymphoma in a geriatric patient with glioblastoma multiforme.
Batalini F; Kaufmann MR; Aleixo GF; Drews R
BMJ Case Rep; 2019 Jun; 12(6):. PubMed ID: 31256047
[TBL] [Abstract][Full Text] [Related]
13. Non-Hodgkin's lymphoma in a patient on treatment with temozolomide.
Otty Z; Sabesan S
Asia Pac J Clin Oncol; 2012 Dec; 8(4):e53-4. PubMed ID: 22897453
[TBL] [Abstract][Full Text] [Related]
14. How lymphotoxic is dose-intensified temozolomide? The glioblastoma experience.
Wick W; Weller M
J Clin Oncol; 2005 Jun; 23(18):4235-6; author reply 4236. PubMed ID: 15961774
[No Abstract] [Full Text] [Related]
15. Fatal reactivation of hepatitis B with temozolomide.
Grewal J; Dellinger CA; Yung WK
N Engl J Med; 2007 Apr; 356(15):1591-2. PubMed ID: 17429098
[No Abstract] [Full Text] [Related]
16. Temozolomide-associated organizing pneumonitis.
Maldonado F; Limper AH; Lim KG; Aubrey MC
Mayo Clin Proc; 2007 Jun; 82(6):771-3. PubMed ID: 17550757
[TBL] [Abstract][Full Text] [Related]
17. [Side effects of temozolomide treatment in patient with glioblastoma multiforme--case study].
Łata S; Molczyk A
Przegl Lek; 2010; 67(5):445-6. PubMed ID: 20684359
[TBL] [Abstract][Full Text] [Related]
18. Pneumocystis jirovecii pneumonia complicating the progress of a patient with glioblastoma multiforme receiving temozolomide.
Gorospe Sarasúa L; Ureña-Vacas A; Muñoz Del Toro JR
Arch Bronconeumol; 2016 Oct; 52(10):534-5. PubMed ID: 27021139
[No Abstract] [Full Text] [Related]
19. Post-operative management of primary glioblastoma multiforme in patients over 60 years of age.
Daróczi B; Szántó E; Tóth J; Barzó P; Bognár L; Bakó G; Szántó J; Mózes P; Hideghéty K
Ideggyogy Sz; 2013 Nov; 66(11-12):391-8. PubMed ID: 24555238
[TBL] [Abstract][Full Text] [Related]
20. Persistent bone marrow depression following short-term treatment with temozolomide.
Vandraas K; Tjønnfjord GE; Johannesen TB; Brandal P
BMJ Case Rep; 2016 Apr; 2016():. PubMed ID: 27130558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
